Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIRST1D: Flat vs. Circadian Insulin Infusion Rates in Type 1 Diabetes
NCT04267770Completed
- Sponsor
- Imperial College London
- Start
- Apr 2018
- Primary completion
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of human insulin in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Imperial College London. Primary endpoint: Change in Basal Insulin Rate at 24 hours. Started Apr 2018; status: completed.
02
Drugs
human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04267770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04267770.